Antileishmanial agent-41
Antileishmanial agent-41 (Compound 20k) is a selective Antileishmanial agent with a IC50 of 1.51 μg/mL against Leishmania donovani. Antileishmanial agent-41 increases ROS levels. Antileishmanial agent-41 can be used for the research of leishmaniasis.
For research use only. We do not sell to patients.
- CAS No.: 3126462-44-7
- Formula: C16H16F3N5O
- Molecular Weight:351.33
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Parasite Isoforms
More
Biological Activity
Description
IC50 & Target
[1]|
Leishmania 1.51 μg/mL (IC50) |
In Vitro
Antileishmanial agent-41 (48 h) exhibits moderate cytotoxicity against RAW 264.7 murine macrophages, with a CC50 value of 6.72 μg/mL[1].
Antileishmanial agent-41 (2-16 μg/mL; 48 h) potently inhibits the growth of Leishmania donovani promastigotes, with an IC50 of 1.51 μg/mL[1].
Antileishmanial agent-41 (1.51 μg/mL; 48 h) induces significant G0/G1 subphase cell cycle arrest in promastigotes of Leishmania donovani[1].
Antileishmanial agent-41 (1.51 μg/mL; 48 h) significantly increases the intracellular reactive oxygen species level in promastigotes of *Leishmania donovani*. After treatment at its IC50 concentration for 48 h, it induces a 5.66-fold increase compared with the untreated control group[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:Leishmania donovani promastigotes
-
Concentration:1.51 μg/mL (IC50 concentration)
-
Incubation Time:48 h
-
Result:Significantly increased the proportion of L. donovani promastigotes in the sub-G0/G1 phase to 65.0% (p < 0.001), compared to 6.8% in untreated controls.
Showed cell cycle arrest comparable to amphotericin B and higher than miltefosine.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c (female, 24-25 g)[1]
-
Dosage:0.5 mg/kg; 1 mg/kg; 2 mg/kg; 5 mg/kg; 10 mg/kg; 20 mg/kg
-
Administration:p.o.; single dose
-
Result:Showed no mortality, abnormal behavior, or visible toxicity signs across all dose groups.
Exhibited negligible body weight changes.
Demonstrated no significant hematological alterations compared to controls.
Revealed normal tissue architecture in liver, spleen, and kidney, with only minor, non-significant alterations in the 10 and 20 mg/kg groups.
Caused slightly elevated serum urea, creatinine, uric acid, cholesterol, triglycerides, HDL, LDL, VLDL, ALT, AST, and ALP levels versus controls at 10 and 20 mg/kg, with all values remaining within reference ranges.
Showed no significant biochemical signs of toxicity in the 0.5 and 1 mg/kg groups.
Chemical Information
-
CAS No. 3126462-44-7
-
Molecular Weight 351.33
-
Formula C16H16F3N5O
-
SMILES
NC1=NC2=CC=C(NC(C(F)(F)F)=O)C=C2C3=CC(CCCC)=NN31
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Antileishmanial agent-41
- 3126462-44-7
- Antileishmanial agent41
- Antileishmanial agent 41
- Parasite
- Reactive Oxygen Species (ROS)
- programmed-like parasite death
- BALB/c mice
- sub-G0/G1 phase
- RAW 264.7 murine macrophages
- epithelial cells
- Leishmania donovani promastigotes
- intracellular reactive oxygen species
- immune cells
- visceral leishmaniasis
- Inhibitor
- inhibitor
- inhibit